Tonix launches its new fibromyalgia drug in US

pharmaphorum·Nov 28

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Tonix has launched a new drug for the treatment of fibromyalgia in the US. The drug, called Tonmya, is reportedly the first new FDA-approved medicine for fibromyalgia in over 15 years. However, there are conflicting reports about the launch, with some indicating it may be slower than expected.

Full coverage

Tonix Pharmaceuticals (TNXP) Investor presentation Summary

Quartr·Jul 17

Tonix launches new oral fibromyalgia treatment

PMLiVE·Nov 27

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

GlobeNewswire·May 28

Tonix Pharmaceuticals Set to Launch Tonmya™ for Fibromyalgia Treatment, First New FDA-Approved Medicine in Over 15 Years

Quiver Quantitative·Nov 10

Why Is TNXP Stock Rising Today?

TradingView·Jun 8

Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment

Yahoo Finance·Nov 17

TNXP Slips After Hours On Slower Than Expected Launch For Fibromyalgia Drug

Stocktwits·May 1

With FDA nod, Tonix's Tonmya becomes first new fibromyalgia treatment in more than 16 years

Fierce Pharma·Aug 15

View original report at pharmaphorum ↗

Fetching the latest headlines…